Competitive Advantages
- Targeted drug delivery to tumors
- Reduced side effects of cancer drugs
- Made of non-toxic, biodegradable protein
- Easily synthesized
Summary
Our inventors have created a novel, cargo carrying nanoparticle for the targeted delivery of drugs to cancer cells. The nanoparticle carries a drug to cancer cells, where the drug is released. This reduces the treatment’s toxicity to healthy tissue. The nanoparticle is made of non-toxic protein, and it can be produced at a low cost. The nanoparticle has molecules that bind to receptors on a cancer cell, which makes the cell engulf any nearby drug loaded particles. This novel type of uptake is advantageous because a single nanoparticle can prompt a cell to take up multiple drug payloads. This system has been shown to be a potential treatment of lung cancer, and it may enable the specific delivery of more chemotherapy drugs to treat other varieties of cancer.
Nanoparticle Structure:
Yellow - Targeting Molecule
Red - Drug Payload
ELP - Structure Protein
Desired Partnerships
- License
- Sponsored Rsearch
- Co-Development